This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Haj-Yahja, S Articles by Shoenfeld, Y Search for Related Content PubMed PubMed Citation Articles by Haj-Yahja, S Articles by Shoenfeld, Y Social Bookmarking                         What's this?

Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model

Center for Autoimmune Diseases, Department of Medicine ‘B’, Tel-Aviv, Israel, Department of Cardiac Surgery, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv, Israel

Y Sherer

Center for Autoimmune Diseases, Department of Medicine ‘B’, Tel-Aviv, Israel

M Blank

Center for Autoimmune Diseases, Department of Medicine ‘B’, Tel-Aviv, Israel

H Kaetsu

The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Kumamoto, Japan

A Smolinsky

Department of Cardiac Surgery, Sheba Medical Center, Tel Hashomer and Sackler Faculty of Medicine, Tel-Aviv, Israel

Y Shoenfeld

Center for Autoimmune Diseases, Department of Medicine ‘B’, Tel-Aviv, Israel, shoenfel{at}post.tau.ac.il

Anti-prothrombin antibodies (aPT) are associated with thrombotic manifestations, and their association with reproductive failure is debatable. The aim of this study was to examine whether aPT could induce thrombosis and other clinical manifestations of the anti-phospholipidsyndrome (APS). Mice were immunized with either prothrombin, b2-glycoprotein-I (b2GPI), or b2GPI followed by prothrombin. The presence of clinical manifestation of APS, including thrombocytopenia, lupus anticoagulant and fetal resorption rates, was evaluated in all mice groups compared with nonimmunized mice. Thrombosis was studied in a novel ex-vivo model in which the aorta was sutured for 1min and the presence or absence of visible thrombus was qualitatively evaluated. Immunized mice developed high autoantibodylevels directed towards their immunizing autoantigens.The groups immunized with b2GPI or b2GPI=prothrombin, but not with prothrombin alone, developed prolonged aPTT, thrombocytopeniaand increased fetal resorption rate. All prothrombin-immunized mice as well as most b2GPI=prothrombin-immunized mice developed visible thrombus within the aorta. Some b2GPI immunized mice developed very mild thrombus. None of the CFA=PBS-injected or the nonimmunized mice developed such thrombus. Active immunization with prothrombin or b2GPI=prothrombin is associated with prothromboticactivity of blood in an ex-vivo model. This is the first direct evidence for thrombus induction by aPT.

Key Words: anti-phospholipid antibody • anti-phospholipid syndrome • prothrombin • thrombosis

Lupus, Vol. 12, No. 5, 364-369 (2003)
DOI: 10.1191/0961203303lu370oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?